about
Early neuroprotection after cardiac arrest.The challenges of multiple organ dysfunction syndrome and extra-corporeal circuits for drug delivery in critically ill patients.How much oxygen in adult cardiac arrest?Neuroprotective strategies and neuroprognostication after cardiac arrest.Altered liver function in patients undergoing veno-arterial extracorporeal membrane oxygenation (ECMO) therapy.C-reactive protein levels after cardiac arrest in patients treated with therapeutic hypothermia.Greater temperature variability is not associated with a worse neurological outcome after cardiac arrest.Acute kidney injury after cardiac arrest.Case Scenario: Perioperative Management of a Young Woman with Fontan Repair for Major Gynecologic Surgery.Lice, rodents, and many hopes: a rare disease in a young refugee.Corrigendum to "C-reactive protein levels after cardiac arrest in patients treated with therapeutic hypothermia" [Resuscitation 85 (2014) 932-938].High-flow oxygen therapy in hypoxemic respiratory failure: insights from the FLORALI trial.Adaptive Support Ventilation From Intubation to Extubation: A Word of Caution.Lung volumes, respiratory mechanics and dynamic strain during general anaesthesiaCardiopulmonary resuscitation above 75 years: is it worthwhile?Out-of-hospital cardiac arrest from neurologic cause: recognition and outcome*Target mean arterial pressure after cardiac arrestLactate measurement after cardiac arrest: tissue hypoxia or adaptive response?*Hypertonic solutions and hydroxyethyl starch during CPR--is there any benefit?Prehospital therapeutic hypothermia in patients with out-of-hospital cardiac arrest
P50
Q34414545-904CB7AC-A4C0-4A28-ADC8-F6E75A31467EQ38212948-4B4CAEEB-797E-4882-8C33-F63088043806Q38337706-C7A3E840-0548-45C3-806A-6D61787FC987Q38670229-E33148F3-B5E1-474B-9A43-AD5E3E6FF9E6Q39011897-B5645858-A24B-49B5-821C-48B467F4CC38Q39207257-399564CE-5CAB-4970-A9CD-292A3722863CQ40138544-1F51156B-8E96-4183-BC50-D16845DAC2D6Q40145360-1BE1653D-B3E7-4AE3-8847-B2C34F99ECD1Q40276381-1DCC0FDF-2AF7-47B7-BFE2-EA2D89711E9BQ42368788-9FF27BE4-746B-4315-9376-62FE21C00EC9Q51522515-A8BD9439-0105-479B-B927-FC5CF360BA41Q51536399-3CDA7738-C1E1-48C2-92DB-B783314D5BA8Q51556953-3C90CA04-1556-4C79-9897-41D62FF02D82Q58545212-92D82725-655E-4C55-9366-CB6869C22B59Q85802353-FDAD09D5-125B-4BB2-B2F2-8CEC7C902B5EQ86554637-0AB9F379-EB7C-4F1C-8C25-C92FC4137A2FQ87091134-0DF27AEA-A24D-4B9D-A888-902911454C4BQ87402623-35E10D37-C4CA-435A-BAF6-29B817C77E31Q87419939-9C6C1259-C018-4B73-998B-7056A022A871Q88011257-CBB804AF-F9B6-4805-933C-16EE43357E19
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Antonio Maria Dell'Anna
@ast
Antonio Maria Dell'Anna
@en
Antonio Maria Dell'Anna
@es
Antonio Maria Dell'Anna
@nl
type
label
Antonio Maria Dell'Anna
@ast
Antonio Maria Dell'Anna
@en
Antonio Maria Dell'Anna
@es
Antonio Maria Dell'Anna
@nl
prefLabel
Antonio Maria Dell'Anna
@ast
Antonio Maria Dell'Anna
@en
Antonio Maria Dell'Anna
@es
Antonio Maria Dell'Anna
@nl
P106
P1153
36460861700
P21
P31
P496
0000-0002-8357-504X